ORPHA:177901
Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1
Publications
4
13.3th percentile
Trials
0
Interventional, condition-specific
Researchers
32
Distinct authors in sample
Gene link
—
Readiness
3/6
Stages with a signal
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0015783
- UMLS:C5680507
Additional Mondo synonyms (1)
Prader-Willi syndrome (Type 1)
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
4 matched papers (2 in last 10 years) Source
- Phenotype characterisedPresent
71 HPO annotations (e.g. Psychosis; Autism; Autistic behavior) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 107 for broader category Prader-Willi syndrome
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
71
Associated phenotypes · MONDO:0015783
- Psychosis
- Autism
- Autistic behavior
- Diabetes mellitus
- External genital hypoplasia
Showing 5 of 71 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
4
4 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
4 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
2 in the last 10 years · high confidence · 13.3th percentile (publications denominator)
Phrase hits: 4 · MeSH hits: 0
Who's working on it?
32
Distinct author names in 4 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Beatty B1 paper · 2026
Department of Indigenous Studies, University of Saskatchewan, Saskatoon, Canada.
Papers in Europe PMC - 02Dai P1 paper · 2023
The College of Life Sciences, Northwest University, Xi'an, Shanxi, China.
Papers in Europe PMC - 03Ding G1 paper · 2023
Department of Obstetrics, Urumqi Maternal and Child Healthcare Hospital, Urumqi, Xinjiang, China.
Papers in Europe PMC - 04Fujimoto M1 paper · 2008Papers in Europe PMC
- 05Gelech J1 paper · 2026
Department of Psychology and Health Studies, University of Saskatchewan, Saskatoon, Canada.
Papers in Europe PMC - 06Graumans R1 paper · 2026
Faculty of Nusing, University of Regina, Regina, Canada.
Papers in Europe PMC - 07Haskell WL1 paper · 2008Papers in Europe PMC
- 08Haydel KF1 paper · 2008Papers in Europe PMC
- 09Killen JD1 paper · 2008Papers in Europe PMC
- 10Kraemer HC1 paper · 2008Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 107 trials are registered for Prader-Willi syndrome, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
107 interventional trials matched Prader-Willi syndrome, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: Prader-Willi syndrome
107
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07219485·ENROLLING BY INVITATION·A Study of Pitolisant in Participants With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT06720571·RECRUITING·Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT03836300·ENROLLING BY INVITATION·Parent and Infant Inter(X)Action Intervention (PIXI)
Conditions: Fragile X Syndrome · Angelman Syndrome · Prader-Willi Syndrome · Dup15Q Syndrome·Matched via name phrase
- NCT05791604·RECRUITING·The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT06901245·RECRUITING·Tirzepatide in PWS, HO and GNSO
Conditions: Prader-Willi Syndrome · Hypothalamic Obesity · Obesity/Therapy·Matched via name phrase
- NCT06366464·RECRUITING·A Study of Pitolisant in Patients With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT06740162·RECRUITING·Physical Activity and Community EmPOWERment Project
Conditions: Intellectual Disability · Neurodevelopmental Disorders · Autism Spectrum Disorder · Down Syndrome·Matched via name phrase
- NCT05938543·RECRUITING·Cerebellar TMS and Satiety in Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT07266324·NOT YET RECRUITING·A 2-Part Study to Assess Efficacy, Safety and Tolerability of BMB-101 for the Treatment of Patients With Prader-Willi Syndrome.
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT07607730·RECRUITING·Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT07006207·NOT YET RECRUITING·Brain Olfactory Pathways in Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT06239116·RECRUITING·A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Conditions: Hypothalamic Obesity · Prader-Willi Syndrome · PWS·Matched via name phrase
- NCT05939453·RECRUITING·Impact of Bright Light Therapy on Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome · Excessive Daytime Sleepiness · Hyperphagia · Body Weight·Matched via name phrase
- NCT07348601·RECRUITING·A Study of CSTI-500 in Patients With Prader-Willi Syndrome
Conditions: Prader-Willi Syndrome·Matched via name phrase
- NCT07122505·RECRUITING·Oromyofunctional Therapy: a Rehabilitation Program for OSA in Children With Down Syndrome and Prader-Willi Syndrome
Conditions: Obstructive Sleep Apnea (OSA) · Orofacial Myofunctional Disorders·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 6 · after dedupe 6 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 6 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (6)
- isrctn·ISRCTN49366748·No longer recruiting·A phase II study to test the safety and effects of BC-006 Injection in adults with obesity
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16634513·Recruiting·Impact of a playful family education strategy with information and communication technology on childhood obesity prevention
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN74656856·No longer recruiting·A study to evaluate the efficacy and safety of Lipoxim Fire for weight management in overweight healthy women
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83070378·No longer recruiting·Effects of nut products on lipid metabolism in obese children
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN39605930·No longer recruiting·'Shape Up-LD': Piloting a manualised weight management programme for overweight and obese persons with mild-moderate learning disabilities
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN19517475·No longer recruiting·Metformin in Obese Children with Abnormal Glucose and Insulin Status
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1 — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26Likely covered — the policy lists Prader-Willi syndrome as a category (Group 2), and this condition is a form of it. Confirm eligibility with a Centre of Excellence.
Group 2 — long-term / lifelong lower-cost interventions
NPRD envisages State Government support for dietary formulae, hormones, and other lower-cost interventions. This is a different route from the central CoE ₹50 lakh pathway; ask your state health department and a CoE which channel applies.
Central CoE funding may also apply depending on current rules — confirm with a notified Centre of Excellence. Do not assume the ₹50 lakh ceiling covers Group 2 by default. Verify
Centres of Excellence (15)
- All India Institute of Medical Sciences (AIIMS) — New Delhi, Delhi
- Maulana Azad Medical College — New Delhi, Delhi
- Sanjay Gandhi Post Graduate Institute of Medical Sciences — Lucknow, Uttar Pradesh
- Post Graduate Institute of Medical Education and Research (PGIMER) — Chandigarh, Chandigarh
- Centre for DNA Fingerprinting & Diagnostics with Nizam’s Institute of Medical Sciences — Hyderabad, Telangana
- King Edward Memorial Hospital — Mumbai, Maharashtra
- Institute of Post-Graduate Medical Education and Research (IPGMER) — Kolkata, West Bengal
- Centre for Human Genetics with Indira Gandhi Hospital — Bengaluru, Karnataka
- Institute of Child Health and Hospital for Children (ICH & HC) — Chennai, Tamil Nadu
- All India Institute of Medical Sciences (AIIMS) — Jodhpur, Rajasthan
- Sree Avittam Thirunal Hospital (SAT), Government Medical College — Thiruvananthapuram, Kerala
- All India Institute of Medical Sciences (AIIMS) — Bhopal, Madhya Pradesh
- Regional Institute of Medical Sciences (RIMS) — Imphal, Manipur
- All India Institute of Medical Sciences (AIIMS) — Patna, Bihar
- Assam Medical College & Hospital — Dibrugarh, Assam
Voluntary contributions / crowdfunding (separate from CoE funding): https://rarediseases.mohfw.gov.in/
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1" OR "Prader-Willi syndrome (Type 1)"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Prader-Willi syndrome due to paternal deletion of 15q11q13 type 1" OR "Prader-Willi syndrome (Type 1)"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"Prader-Willi syndrome"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T08:45:36.596Z
